Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Mereo Biopharma Group PLC
13G/A
Amendment 7
MREO · 589492107
|
0% |
2/17/2026
Event 12/31/2025
|
|||
|
Akero Therapeutics, Inc.
13G/A
Amendment 12
AKRO · 00973Y108
|
4.1% |
2/17/2026
Event 12/31/2025
|
|||
|
Avadel Pharmaceuticals PLC
13G/A
Amendment 7
AVDL · G29687103
|
1.9% |
2/17/2026
Event 12/31/2025
|
|||
|
Avidity Biosciences, Inc.
13G/A
Amendment 4
RNAM · 05370A108
|
4.6% |
2/17/2026
Event 12/31/2025
|
|||
|
Equillium, Inc.
13G/A
Amendment 1
EQ · 29446K106
|
10.0% |
2/6/2026
Event 1/30/2026
|
|||
|
Relmada Therapeutics, Inc.
13G
RLMD · 75955J402
|
10.1% |
2/6/2026
Event 1/30/2026
|
|||
|
Biohaven Ltd.
13G/A
Amendment 1
BHVN · G1110E107
|
12.7% |
2/6/2026
Event 1/30/2026
|
|||
|
DBV Technologies S.A.
13G/A
Amendment 2
DBV.PA · F2927N109
|
8.8% |
1/8/2026
Event 12/31/2025
|
|||
|
CAMP4 Therapeutics Corp
13G
CAMP · 13463J101
|
12.2% |
1/8/2026
Event 12/31/2025
|
|||
|
DBV Technologies S.A.
13G/A
Amendment 1
DBV.PA · F2927N109
|
2.6% |
12/12/2025
Event 11/28/2025
|
|||
|
Tenax Therapeutics, Inc.
13G
TENX · 88032L605
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Pasithea Therapeutics Corp.
13G
KTTA · 70261F202
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Palisade Bio, Inc.
13G
PALI · 696389402
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
| Janus Henderson Group PLC | 10.0% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.0% | ||||
|
Palatin Technologies Inc
13G
PTN · 696077601
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
| Janus Henderson Group PLC | 10.0% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.6% | ||||
|
Ovid Therapeutics Inc.
13G
OVID · 690469101
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Ocugen, Inc.
13G
OCGN · 67577C105
|
6.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Lexeo Therapeutics, Inc.
13G/A
Amendment 7
LXEO · 52886X107
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Inovio Pharmaceuticals, Inc.
13G/A
Amendment 1
INO · 45773H409
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Immunic, Inc.
13G
IMUX · 4525EP101
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Equillium, Inc.
13G
EQ · 29446K106
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
DBV Technologies S.A.
13G
DBV.PA · F2927N109
|
9.5% |
12/8/2025
Event 11/28/2025
|
|||
|
Biomea Fusion, Inc.
13G
BMEA · 09077A106
|
5.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Benitec Biopharma Inc.
13G/A
Amendment 10
BNTC · 08205P209
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
| Janus Henderson Group PLC | 10.0% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.1% | ||||
|
Assembly Biosciences, Inc.
13G
ASMB · 045396207
|
8.2% |
12/8/2025
Event 11/28/2025
|
|||
|
Avidity Biosciences, Inc.
13G/A
Amendment 4
RNAM · 05370A108
|
5.5% |
12/5/2025
Event 11/28/2025
|
|||
|
Mirum Pharamaceuticals, Inc.
13G/A
Amendment 7
MIRM · 604749101
|
10.6% |
12/5/2025
Event 11/28/2025
|
|||
|
Travere Therapeutics, Inc
13G/A
Amendment 2
TVTX · 89422G107
|
11.9% |
11/14/2025
Event 9/30/2025
|
|||
|
Monopar Therapeutics Inc
13G/A
Amendment 4
MNPR · 61023L207
|
19.5% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 19.5% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 16.7% | ||||
|
Maze Therapeutics, Inc.
13G/A
Amendment 2
MAZE · 578784100
|
7.3% |
11/14/2025
Event 9/30/2025
|
|||
|
Lexeo Therapeutics, Inc.
13G/A
Amendment 6
LXEO · 52886X107
|
11.3% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 11.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 7.6% | ||||
|
Ligand Pharmaceuticals Incorporated
13G/A
Amendment 9
LGND · 53220K504
|
5.3% |
11/14/2025
Event 9/30/2025
|
|||
|
Sensient Technologies Corporation
13G/A
Amendment 12
SXT · 81725T100
|
5.4% |
11/14/2025
Event 9/30/2025
|
|||
|
Rentokil Initial PLC
13G/A
Amendment 4
RKLIF · G7494G105
|
5.6% |
11/14/2025
Event 9/30/2025
|
|||
|
Ardelyx, Inc.
13G/A
Amendment 8
ARDX · 039697107
|
5.7% |
11/14/2025
Event 9/30/2025
|
|||
|
Osi Systems, Inc.
13G/A
Amendment 12
OSIS · 671044105
|
5.9% |
11/14/2025
Event 9/30/2025
|
|||
|
Dayforce, Inc.
13G/A
Amendment 1
DAY · 15677J108
|
6.0% |
11/14/2025
Event 9/30/2025
|
|||
|
Revolution Medicines, Inc.
13G/A
Amendment 3
RVMD · 76155X100
|
6.1% |
11/14/2025
Event 9/30/2025
|
|||
|
Asure Software Inc
13G/A
Amendment 4
ASUR · 04649U102
|
6.1% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 6.1% | ||||
| Janus Henderson Venture Fund | 5.7% | ||||
|
Revvity, Inc.
13G/A
Amendment 1
RVTY · 714046109
|
6.6% |
11/14/2025
Event 9/30/2025
|
|||
|
SS&C Technologies Holdings, Inc.
13G/A
Amendment 12
SSNC · 78467J100
|
6.8% |
11/14/2025
Event 9/30/2025
|
|||
|
Sensata Technologies Holding PLC
13G/A
Amendment 11
ST · G8060N102
|
6.9% |
11/14/2025
Event 9/30/2025
|
|||
|
Flex Ltd.
13G/A
Amendment 6
FLEX · Y2573F102
|
7.0% |
11/14/2025
Event 9/30/2025
|
|||
|
Gildan Activewear Inc
13G/A
Amendment 2
GIL · 375916103
|
7.0% |
11/14/2025
Event 9/30/2025
|
|||
|
Ideaya Biosciences, Inc.
13G/A
Amendment 5
IDYA · 45166A102
|
7.3% |
11/14/2025
Event 9/30/2025
|
|||
|
Avadel Pharmaceuticals PLC
13G/A
Amendment 6
AVDL · G29687103
|
7.7% |
11/14/2025
Event 9/30/2025
|
|||
|
Structure Therapeutics Inc
13G/A
Amendment 4
GPCR · 86366E106
|
7.7% |
11/14/2025
Event 9/30/2025
|
|||
|
Akero Therapeutics, Inc.
13G/A
Amendment 11
AKRO · 00973Y108
|
7.9% |
11/14/2025
Event 9/30/2025
|
|||
|
Madrigal Pharmaceuticals, Inc.
13G/A
Amendment 7
MDGL · 558868105
|
8.3% |
11/14/2025
Event 9/30/2025
|
|||
|
Ziff Davis, Inc.
13G/A
Amendment 7
ZD · 48123V102
|
8.4% |
11/14/2025
Event 9/30/2025
|
|||
|
Liberty Media Corporation
13G/A
Amendment 10
FWONK · 531229755
|
4.8% |
11/14/2025
Event 9/30/2025
|
|||
|
Lantheus Holdings, Inc.
13G/A
Amendment 5
LNTH · 516544103
|
9.8% |
11/14/2025
Event 9/30/2025
|
|||
|
Mirum Pharamaceuticals, Inc.
13G/A
Amendment 6
MIRM · 604749101
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
|
Vaxcyte, Inc.
13G/A
Amendment 8
PCVX · 92243G108
|
10.1% |
11/14/2025
Event 9/30/2025
|
|||
|
Surgery Partners, Inc.
13G/A
Amendment 3
SGRY · 86881A100
|
10.2% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 10.2% | ||||
| Janus Henderson Contrarian Fund | 9.7% | ||||
|
Mereo Biopharma Group PLC
13G/A
Amendment 6
MREO · 589492107
|
10.2% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 10.2% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 8.7% | ||||
|
Dyne Therapeutics Inc
13G/A
Amendment 4
DYN · 26818M108
|
10.4% |
11/14/2025
Event 9/30/2025
|
|||
|
Avidity Biosciences, Inc.
13G/A
Amendment 3
RNAM · 05370A108
|
10.7% |
11/14/2025
Event 9/30/2025
|
|||
|
Protara Therapeutics, Inc.
13G/A
Amendment 4
TARA · 74365U107
|
11.0% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 11.0% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.3% | ||||
|
Soleno Therapeutics, Inc.
13G/A
Amendment 7
SLNO · 834203309
|
11.4% |
11/14/2025
Event 9/30/2025
|
|||
|
Invivyd, Inc.
13G/A
Amendment 1
IVVD · 00534A102
|
12.1% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 12.1% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.3% | ||||
|
Praxis Precision Medicines, Inc
13G/A
Amendment 3
PRAX · 74006W207
|
12.3% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 12.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.2% | ||||
|
Consensus Cloud Solutions, Inc.
13G/A
Amendment 7
CCSI · 20848V105
|
13.1% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 13.1% | ||||
| Janus Henderson Triton Fund | 7.0% | ||||
|
Cimpress PLC
13G/A
Amendment 14
CMPR · G2143T103
|
13.7% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 13.7% | ||||
| Janus Henderson Enterprise Fund | 9.6% | ||||
|
Ascendis Pharma A/S
13G/A
Amendment 8
ASND · 04351P101
|
7.8% |
11/14/2025
Event 9/30/2025
|
|||
|
Inovio Pharamaceuiticals, Inc.
13G
INO · 45773H409
|
6.2% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 6.2% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.3% | ||||
|
Metsera, Inc.
13G
MTSR · 59267L107
|
5.1% |
11/14/2025
Event 9/30/2025
|
|||
|
Xenon Pharmaceuticals Inc.
13G
XENE · 98420N105
|
5.1% |
11/14/2025
Event 9/30/2025
|
|||
|
Olema Pharmaceuticals, Inc.
13G
OLMA · 68062P106
|
5.2% |
11/14/2025
Event 9/30/2025
|
|||
|
Api Group Corp
13G
APG · 00187Y100
|
5.3% |
11/14/2025
Event 9/30/2025
|
|||
|
Biohaven Ltd.
13G
BHVN · G1110E107
|
6.4% |
11/14/2025
Event 9/30/2025
|
|||
|
Verona Pharma PLC
13G/A
Amendment 2
VRNA · 925050106
|
1.2% |
11/14/2025
Event 9/30/2025
|
|||
|
Amdocs Limited
13G/A
Amendment 11
DOX · G02602103
|
2.3% |
11/14/2025
Event 9/30/2025
|
|||
|
Edgewise Therapeutics, Inc.
13G/A
Amendment 3
EWTX · 28036F105
|
4.7% |
11/14/2025
Event 9/30/2025
|
|||
|
Inspired Entertainment, Inc
13G/A
Amendment 2
INSE · 45782N108
|
4.9% |
11/14/2025
Event 9/30/2025
|
|||
|
Janux Therapeutics, Inc.
13G/A
Amendment 3
JANX · 47103J105
|
10.0% |
11/7/2025
Event 10/31/2025
|
|||
|
Enanta Pharmaceuticals Inc
13G
ENTA · 29251M106
|
12.1% |
11/7/2025
Event 10/31/2025
|
|||
| Janus Henderson Group PLC | 12.1% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.6% | ||||
|
89bio, Inc.
13G/A
Amendment 8
ETNB · 282559103
|
3.6% |
10/7/2025
Event 9/30/2025
|
|||
|
Invivyd, Inc.
13G
IVVD · 00534A102
|
11.6% |
9/8/2025
Event 8/29/2025
|
|||
|
Vistagen Therapeutics, Inc.
13G
VTGN · 92840H400
|
13.6% |
9/8/2025
Event 8/29/2025
|
|||
| Janus Henderson Group PLC | 13.6% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 11.7% | ||||
|
Benitec Biopharma Inc.
13G/A
Amendment 9
BNTC · 08205P209
|
11.3% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 11.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 8.6% | ||||
|
Maze Therapeutics, Inc.
13G/A
Amendment 1
MAZE · 578784100
|
6.0% |
8/14/2025
Event 3/31/2025
|
|||
|
Lexeo Therapeutics, Inc.
13G/A
Amendment 5
LXEO · 52886X107
|
11.1% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 11.1% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.2% | ||||
|
Forte Biosciences, Inc.
13G/A
Amendment 2
FBRX · 34962G208
|
9.9% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 9.9% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.9% | ||||
|
Benitec Biopharma Inc.
13G/A
Amendment 8
BNTC · 08205P209
|
11.3% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 11.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 8.6% | ||||
|
Inspired Entertainment, Inc
13G/A
Amendment 1
INSE · 45782N108
|
5.0% |
8/14/2025
Event 6/30/2025
|
|||
|
Amdocs Limited
13G/A
Amendment 10
DOX · G02602103
|
5.2% |
8/14/2025
Event 6/30/2025
|
|||
|
Edgewise Therapeutics, Inc.
13G/A
Amendment 2
EWTX · 28036F105
|
5.2% |
8/14/2025
Event 6/30/2025
|
|||
|
Tyra Biosciences, Inc
13G/A
Amendment 1
TYRA · 90240B106
|
5.4% |
8/14/2025
Event 6/30/2025
|
|||
|
Sensient Technologies Corporation
13G/A
Amendment 11
SXT · 81725T100
|
5.5% |
8/14/2025
Event 6/30/2025
|
|||
|
Ligand Pharmaceuticals Incorporated
13G/A
Amendment 8
LGND · 53220K504
|
5.5% |
8/14/2025
Event 6/30/2025
|
|||
|
Rentokil Initial PLC
13G/A
Amendment 3
RKLIF · G7494G105
|
5.7% |
8/14/2025
Event 6/30/2025
|
|||
|
Revolution Medicines, Inc.
13G/A
Amendment 2
RVMD · 76155X100
|
5.7% |
8/14/2025
Event 6/30/2025
|
|||
|
Osi Systems, Inc.
13G/A
Amendment 11
OSIS · 671044105
|
6.3% |
8/14/2025
Event 6/30/2025
|
|||
|
Ardelyx, Inc.
13G/A
Amendment 7
ARDX · 039697107
|
6.3% |
8/14/2025
Event 6/30/2025
|
|||
|
Asure Software Inc
13G/A
Amendment 3
ASUR · 04649U102
|
6.3% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 6.3% | ||||
| Janus Henderson Venture Fund | 5.9% | ||||
|
Gildan Activewear Inc
13G/A
Amendment 1
GIL · 375916103
|
6.6% |
8/14/2025
Event 6/30/2025
|
|||
|
SS&C Technologies Holdings, Inc.
13G/A
Amendment 11
SSNC · 78467J100
|
6.7% |
8/14/2025
Event 6/30/2025
|
|||
|
Sensata Technologies Holding PLC
13G/A
Amendment 10
ST · G8060N102
|
6.8% |
8/14/2025
Event 6/30/2025
|
|||
|
Aramark
13G/A
Amendment 3
ARMK · 03852U106
|
6.9% |
8/14/2025
Event 6/30/2025
|
|||
|
Ideaya Biosciences, Inc.
13G/A
Amendment 4
IDYA · 45166A102
|
6.9% |
8/14/2025
Event 6/30/2025
|
|||